Genetic Engineering Drug Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibody, Recombinant Human Erythropoietin, Recombinant Human Interferon, Recombinant Human Growth Hormone, Recombinant Human Insulin); End users (Pharmaceutical Industries, Academic Institutes, Agriculture, Others), and geography

Report Code: TIPRE00020932 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Genetic engineering drugs has applications in research, medicine, agriculture, and industry and can be used on a broad range of plants, animals and microorganisms. In medicine, genetic engineering has been used to mass-produce human albumin, human growth hormones, follistim (for treating infertility), insulin, antihemophilic factors, monoclonal antibodies, vaccines, and many other drugs. In research, Organisms are genetically modified in experiments to learn more about the roles of specific genes. Transforming microorganisms such as bacteria or yeast, or insect mammalian cells with a gene coding for a useful protein, are examples of industrial applications. The protein can be produced in large amounts by fermenting the transformed organism in bioreactors and then purifying the protein.

MARKET DYNAMICS

Factors driving the growth of the genetic engineering drug market are the growing development of novel technologies in genome engineering, coupled with rising funding and investments for the development and research of new genetic engineering technologies. However, the high cost of genome engineering technology and needs high skilled researchers, which limits its adoption rate is expected to hamper the growth of the market. Moreover, increasing strategic collaboration for genome engineering drugs is anticipated to boost the market growth.

MARKET SCOPE

The "Genetic Engineering Drug Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of genetic engineering drug market with detailed market segmentation by product type and end user. The genetic engineering drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in genetic engineering drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The genetic engineering drug market is segmented on the basis of product type and end users. Based on product type, the market is segmented as monoclonal antibody, recombinant human erythropoietin, recombinant human interferon, recombinant human growth hormone, and recombinant human insulin. On the basis of end users, the market is categorized as pharmaceutical industries, academic institutes agriculture, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the genetic engineering drug market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genetic engineering drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting genetic engineering drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the genetic engineering drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the genetic engineering drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from genetic engineering drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for genetic engineering drug in the global market. Below mentioned is the list of few companies engaged in the genetic engineering drug market.

The report also includes the profiles of key players in genetic engineering drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Shanghai Lansheng Guojian Pharmaceutical
  •   Biotech Pharmaceutical
  •   GeneScience Pharmaceuticals
  •   Beijing SL Pharmaceutical
  •   Anhui Anke Biotechnology
  •   3SBio
  •   Jiangsu Sihuan Bioengineering
  •   Tonghua Dongbao Pharmaceutical
  •   Shenzhen Neptunus Interlong Bio-Technique
  •   Others

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genetic Engineering Drug Market - By Product Type
1.3.2 Genetic Engineering Drug Market - By End users
1.3.3 Genetic Engineering Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENETIC ENGINEERING DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENETIC ENGINEERING DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENETIC ENGINEERING DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. GENETIC ENGINEERING DRUG - GLOBAL MARKET OVERVIEW
6.2. GENETIC ENGINEERING DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GENETIC ENGINEERING DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODY
7.3.1. Overview
7.3.2. Monoclonal Antibody Market Forecast and Analysis
7.4. RECOMBINANT HUMAN ERYTHROPOIETIN
7.4.1. Overview
7.4.2. Recombinant Human Erythropoietin Market Forecast and Analysis
7.5. RECOMBINANT HUMAN INTERFERON
7.5.1. Overview
7.5.2. Recombinant Human Interferon Market Forecast and Analysis
7.6. RECOMBINANT HUMAN GROWTH HORMONE
7.6.1. Overview
7.6.2. Recombinant Human Growth Hormone Market Forecast and Analysis
7.7. RECOMBINANT HUMAN INSULIN
7.7.1. Overview
7.7.2. Recombinant Human Insulin Market Forecast and Analysis
8. GENETIC ENGINEERING DRUG MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
8.1. OVERVIEW
8.2. END USERS MARKET FORECASTS AND ANALYSIS
8.3. PHARMACEUTICAL INDUSTRIES
8.3.1. Overview
8.3.2. Pharmaceutical Industries Market Forecast and Analysis
8.4. ACADEMIC INSTITUTES
8.4.1. Overview
8.4.2. Academic Institutes Market Forecast and Analysis
8.5. AGRICULTURE
8.5.1. Overview
8.5.2. Agriculture Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. GENETIC ENGINEERING DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Genetic Engineering Drug Market Overview
9.1.2 North America Genetic Engineering Drug Market Forecasts and Analysis
9.1.3 North America Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.1.4 North America Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.1.5 North America Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Genetic Engineering Drug Market
9.1.5.1.1 United States Genetic Engineering Drug Market by Product Type
9.1.5.1.2 United States Genetic Engineering Drug Market by End users
9.1.5.2 Canada Genetic Engineering Drug Market
9.1.5.2.1 Canada Genetic Engineering Drug Market by Product Type
9.1.5.2.2 Canada Genetic Engineering Drug Market by End users
9.1.5.3 Mexico Genetic Engineering Drug Market
9.1.5.3.1 Mexico Genetic Engineering Drug Market by Product Type
9.1.5.3.2 Mexico Genetic Engineering Drug Market by End users
9.2. EUROPE
9.2.1 Europe Genetic Engineering Drug Market Overview
9.2.2 Europe Genetic Engineering Drug Market Forecasts and Analysis
9.2.3 Europe Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.2.4 Europe Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.2.5 Europe Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Genetic Engineering Drug Market
9.2.5.1.1 Germany Genetic Engineering Drug Market by Product Type
9.2.5.1.2 Germany Genetic Engineering Drug Market by End users
9.2.5.2 France Genetic Engineering Drug Market
9.2.5.2.1 France Genetic Engineering Drug Market by Product Type
9.2.5.2.2 France Genetic Engineering Drug Market by End users
9.2.5.3 Italy Genetic Engineering Drug Market
9.2.5.3.1 Italy Genetic Engineering Drug Market by Product Type
9.2.5.3.2 Italy Genetic Engineering Drug Market by End users
9.2.5.4 Spain Genetic Engineering Drug Market
9.2.5.4.1 Spain Genetic Engineering Drug Market by Product Type
9.2.5.4.2 Spain Genetic Engineering Drug Market by End users
9.2.5.5 United Kingdom Genetic Engineering Drug Market
9.2.5.5.1 United Kingdom Genetic Engineering Drug Market by Product Type
9.2.5.5.2 United Kingdom Genetic Engineering Drug Market by End users
9.2.5.6 Rest of Europe Genetic Engineering Drug Market
9.2.5.6.1 Rest of Europe Genetic Engineering Drug Market by Product Type
9.2.5.6.2 Rest of Europe Genetic Engineering Drug Market by End users
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Genetic Engineering Drug Market Overview
9.3.2 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.3.5 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Genetic Engineering Drug Market
9.3.5.1.1 Australia Genetic Engineering Drug Market by Product Type
9.3.5.1.2 Australia Genetic Engineering Drug Market by End users
9.3.5.2 China Genetic Engineering Drug Market
9.3.5.2.1 China Genetic Engineering Drug Market by Product Type
9.3.5.2.2 China Genetic Engineering Drug Market by End users
9.3.5.3 India Genetic Engineering Drug Market
9.3.5.3.1 India Genetic Engineering Drug Market by Product Type
9.3.5.3.2 India Genetic Engineering Drug Market by End users
9.3.5.4 Japan Genetic Engineering Drug Market
9.3.5.4.1 Japan Genetic Engineering Drug Market by Product Type
9.3.5.4.2 Japan Genetic Engineering Drug Market by End users
9.3.5.5 South Korea Genetic Engineering Drug Market
9.3.5.5.1 South Korea Genetic Engineering Drug Market by Product Type
9.3.5.5.2 South Korea Genetic Engineering Drug Market by End users
9.3.5.6 Rest of Asia-Pacific Genetic Engineering Drug Market
9.3.5.6.1 Rest of Asia-Pacific Genetic Engineering Drug Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Genetic Engineering Drug Market by End users
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Genetic Engineering Drug Market Overview
9.4.2 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.4.5 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Genetic Engineering Drug Market
9.4.5.1.1 South Africa Genetic Engineering Drug Market by Product Type
9.4.5.1.2 South Africa Genetic Engineering Drug Market by End users
9.4.5.2 Saudi Arabia Genetic Engineering Drug Market
9.4.5.2.1 Saudi Arabia Genetic Engineering Drug Market by Product Type
9.4.5.2.2 Saudi Arabia Genetic Engineering Drug Market by End users
9.4.5.3 U.A.E Genetic Engineering Drug Market
9.4.5.3.1 U.A.E Genetic Engineering Drug Market by Product Type
9.4.5.3.2 U.A.E Genetic Engineering Drug Market by End users
9.4.5.4 Rest of Middle East and Africa Genetic Engineering Drug Market
9.4.5.4.1 Rest of Middle East and Africa Genetic Engineering Drug Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Genetic Engineering Drug Market by End users
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Genetic Engineering Drug Market Overview
9.5.2 South and Central America Genetic Engineering Drug Market Forecasts and Analysis
9.5.3 South and Central America Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.5.5 South and Central America Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Genetic Engineering Drug Market
9.5.5.1.1 Brazil Genetic Engineering Drug Market by Product Type
9.5.5.1.2 Brazil Genetic Engineering Drug Market by End users
9.5.5.2 Argentina Genetic Engineering Drug Market
9.5.5.2.1 Argentina Genetic Engineering Drug Market by Product Type
9.5.5.2.2 Argentina Genetic Engineering Drug Market by End users
9.5.5.3 Rest of South and Central America Genetic Engineering Drug Market
9.5.5.3.1 Rest of South and Central America Genetic Engineering Drug Market by Product Type
9.5.5.3.2 Rest of South and Central America Genetic Engineering Drug Market by End users
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GENETIC ENGINEERING DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENETIC ENGINEERING DRUG MARKET, KEY COMPANY PROFILES
12.1. SHANGHAI LANSHENG GUOJIAN PHARMACEUTICAL
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOTECH PHARMACEUTICAL
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GENESCIENCE PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BEIJING SL PHARMACEUTICAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ANHUI ANKE BIOTECHNOLOGY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. 3SBIO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JIANGSU SIHUAN BIOENGINEERING
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TONGHUA DONGBAO PHARMACEUTICAL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. OTHERS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Shanghai Lansheng Guojian Pharmaceutical
2. Biotech Pharmaceutical
3. GeneScience Pharmaceuticals
4. Beijing SL Pharmaceutical
5. Anhui Anke Biotechnology
6. 3SBio
7. Jiangsu Sihuan Bioengineering
8. Tonghua Dongbao Pharmaceutical
9. Shenzhen Neptunus Interlong Bio-Technique
10. Others
TIPRE00020932
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking